Immunotherapy sheds new light to cancer treatment and is satisfied by cancer patients.
However, immunotoxicity, single‐source antibodies, and single‐targeting stratege are …

The essential goal of vaccination is to generate potent and long-term protection against
diseases. Among different vaccine modalities, prime-boost vaccine strategies could …

The present invention relates to an immunogenic composi tion. More particularly, the
present invention is a composition directed to eliciting an immune response to at least one …

There is currently sufficient evidence to conclude that human papillomavirus (HPV) plays a
role in the pathogenesis of a distinct subset of head and neck squamous cell cancers …

Peptides bound or linked to heat-shock proteins (HSPs) of microbial or mammalian origin
have been shown to elicit potent antigen-specific immunity. Some members of the HSP …

Microneedles were first conceptualized for drug delivery many decades ago, overcoming the
shortages and preserving the advantages of hypodermic needle and conventional …

We contrast the efforts to treat ovarian cancer and cervical cancer through vaccination
because of their different pathobiology. A plethora of approaches have been developed for …

Until recently, immunotherapies have been of limited success, particularly against cancer.
However, recent insights into the cells, molecules and signalling pathways that regulate …

Immunotherapy for cervical cancer should target high-risk human papillomavirus types 16
and 18, which cause 50% and 20% of cervical cancers, respectively. Here, we describe the …

Antigen-specific cancer immunotherapy and antiangiogenesis have emerged as two
attractive strategies for cancer treatment. An innovative approach that combines both …